Follow
Mario Poljak
Mario Poljak
Professor of Microbiology and Immunology
Verified email at mf.uni-lj.si - Homepage
Title
Cited by
Cited by
Year
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer
M Arbyn, G Ronco, A Anttila, CJLM Meijer, M Poljak, G Ogilvie, ...
Vaccine 30, F88-F99, 2012
9582012
Comprehensive control of human papillomavirus infections and related diseases
FX Bosch, TR Broker, D Forman, AB Moscicki, ML Gillison, J Doorbar, ...
Vaccine 31, H1-H31, 2013
7762013
HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients
X Castellsagué, L Alemany, M Quer, G Halec, B Quirós, S Tous, ...
Journal of the National Cancer Institute 108 (6), djv403, 2016
7702016
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide
L Alemany, M Saunier, I Alvarado‐Cabrero, B Quirós, J Salmeron, ...
International journal of cancer 136 (1), 98-107, 2015
4272015
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
M Arbyn, PJF Snijders, CJLM Meijer, J Berkhof, K Cuschieri, BJ Kocjan, ...
Clinical Microbiology and Infection 21 (9), 817-826, 2015
3142015
Transmission of drug-resistant HIV-1 is stabilizing in Europe
J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ...
The Journal of infectious diseases 200 (10), 1503-1508, 2009
3112009
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis
SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ...
PLoS medicine 12 (4), e1001810, 2015
2812015
Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail
M Poljak, IJ Marin, K Seme, A Vince
Journal of Clinical Virology 25, 89-97, 2002
2362002
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans
PJ Maver, M Poljak
Clinical microbiology and infection 26 (5), 579-583, 2020
2212020
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
FX Bosch, C Robles, M Diaz, M Arbyn, I Baussano, C Clavel, G Ronco, ...
Nature reviews Clinical oncology 13 (2), 119-132, 2016
2152016
European recommendations for the clinical use of HIV drug resistance testing: 2011 update
AM Vandamme, RJ Camacho, F Ceccherini-Silberstein, A De Luca, ...
Aids Rev 13 (2), 77-108, 2011
1902011
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2016
1872016
Transmission of Mycobacterium tuberculosis from Human to Cattle
M Ocepek, M Pate, M Zolnir-Dovc, M Poljak
Journal of clinical microbiology 43 (7), 3555-3557, 2005
1842005
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ...
Retrovirology 10, 1-13, 2013
1812013
Update from the 4th edition of the World Health Organization classification of head and neck tumours: what is new in the 2017 WHO blue book for tumours of the hypopharynx …
N Gale, M Poljak, N Zidar
Head and neck pathology 11, 23-32, 2017
1772017
Current review on squamous intraepithelial lesions of the larynx
N Gale, L Michaels, B Luzar, M Poljak, N Zidar, J Fischinger, A Cardesa
Histopathology 54 (6), 639-656, 2009
1722009
Commercially available molecular tests for human papillomaviruses (HPV): 2015 update
M Poljak, BJ Kocjan, A Oštrbenk, K Seme
Journal of Clinical Virology 76, S3-S13, 2016
1612016
Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017
P Ndumbi, GS Freidl, CJ Williams, O Mårdh, C Varela, A Avellón, ...
Eurosurveillance 23 (33), 1700641, 2018
1602018
Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic
M Poljak, M Korva, N Knap Gašper, K Fujs Komloš, M Sagadin, T Uršič, ...
Journal of Clinical Microbiology 58 (6), 10.1128/jcm. 00599-20, 2020
1572020
Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis
L Bruni, B Serrano, E Roura, L Alemany, M Cowan, R Herrero, M Poljak, ...
The Lancet Global Health 10 (8), e1115-e1127, 2022
1562022
The system can't perform the operation now. Try again later.
Articles 1–20